Qsymia clinical trials
How each study uses Qsymia is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Qsymia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Qsymia
- 7
Studies by the year they started
10 studies that test it; most in 2014 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 8
University of Minnesota (2) · Mayo Clinic (2) · VIVUS LLC (2) · Seattle Children's Hospital (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Alvogen Korea (1) · Stanford University (1) · Lindner Center of HOPE (1)
Often tested with
Tested in the same studies.
Propranolol (1) · Pindolol (1) · Dantrolene (1) · Magnesium Sulfate (1) · Caffeine (1) · Topiramate (1) · Naltrexone (1) · Mirabegron (1)
Studies
Open first, then newest update. How each study uses Qsymia is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 11
- Weight Gain Prevention in Adolescents and Young AdultsRecruitingPhase 3University of MinnesotaNCT06905626Written as Qsymia 7.5 miligrams (mg)-46 mg Extended Release CapsuleHow we know
- Phentermine/Topiramate in Adolescents With Type 2 Diabetes and ObesityCompletedEarly Phase 1University of MinnesotaNCT04881799Written as Phentermine/Topiramate (Qsymia)How we know
- Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic ObesityActive, not recruitingPhase 2Seattle Children's HospitalNCT06299891Written as Phentermine / Topiramate Extended Release Oral Capsule [Qsymia]How we know
- Study of Human Non-Shivering Thermogenesis and Basal Metabolic RateCompletedPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT01950520Written as QsymiaHow we know
- Phase IV Study of Qsymia in Obese PatientsCompletedPhase 4Alvogen KoreaNCT05378503Written as Qsymia 3.75Mg-23Mg Extended Release CapsuleHow we know
- Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity TrackerCompletedPhase 4Mayo ClinicNCT04408586Written as Phentermine-Topiramate Extended ReleaseHow we know
- A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With ObesityCompletedPhase 4VIVUS LLCNCT03922945Written as VI-0521 oral capsuleHow we know
- FDA Approved Medication to Reduce Binge Eating and/or PurgingCompletedPhase 1Stanford UniversityNCT02553824Written as Phentermine/Topiramate-FirstHow we know
- Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy SubjectsCompletedPhase 4VIVUS LLCNCT02229214Written as QsymiaHow we know
- Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)CompletedPhase 2Lindner Center of HOPENCT02659475Written as PHEN/TPM ER (Qsymia®)How we know
- Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese PatientsCompletedPhase 4Mayo ClinicNCT01834404Written as Phentermine-Topiramate ERHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Started recruiting1
- Weight Gain Prevention in Adolescents and Young AdultsNov 4, 2026NCT06905626